- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.01. | Vibrant Therapeutics raises $61m in funding to advance intelligent therapeutics pipeline | ||
| 16.01. | Vibrant Therapeutics appoints Han Lee as co-CEO | ||
| 16.01. | From patients to consumers: why pharma communications must rethink the rules of engagement | ||
| 15.01. | Takeda's zasocitinib demonstrates positive results in plaque psoriasis | ||
| 15.01. | NanoSyrinx appoints Thomas J Farrell as CEO | ||
| 14.01. | VML Health appoints Nadine Leonard as Global Chief Solutions & Innovation Officer | ||
| 14.01. | AbbVie reaches agreement for affordable prescription drugs with US government | ||
| 13.01. | Novo Nordisk's Wegovy higher dose injection approved by UK MHRA for obesity | ||
| 13.01. | Enhanced Genomics appoints Katerina Leftheris to Board of Directors | ||
| 12.01. | Johnson & Johnson's Rybrevant shows positive effects in difficult-to-treat colorectal cancer | ||
| 12.01. | Pfizer's Braftovi combination therapy shows positive results for colorectal cancer | ||
| 09.01. | BMS announces affordable drug price agreement with US government | ||
| 09.01. | Gilead appoints Keeley Wettan as Executive VP, General Counsel, Legal & Compliance | ||
| 08.01. | Lilly announces acquisition of Ventyx Biosciences for around $1.2bn | ||
| 08.01. | AstraZeneca's Saphnelo demonstrates positive results in systemic lupus erythematosus | ||
| 07.01. | Excellence in Healthcare Partnerships Awards and Networking Evening | ||
| 07.01. | GSK's Nucala approved by MHRA for uncontrolled COPD | ||
| 07.01. | Amgen agrees to lower prescription drug costs in deal with US government | ||
| 06.01. | Gilead agrees on affordable medicines plan with US government | ||
| 06.01. | Novartis agrees to lower drug prices in deal with US government | ||
| 05.01. | Merck announces agreement with US government to reduce prices of prescription medication | ||
| 05.01. | Novo Nordisk's Wegovy approved by FDA as oral medication for weight management | ||
| 19.12.25 | Galderma's Nemluvio rapidly relieves atopic dermatitis and prurigo nodularis symptoms | ||
| 19.12.25 | Lilly announces new study data on Inluriyo in metastatic breast cancer | ||
| 18.12.25 | The next era in life sciences: agentic AI and other innovations transforming HCP engagement |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.